CA2920505C - Process for the purification of diaminophenothiazinium compounds - Google Patents
Process for the purification of diaminophenothiazinium compounds Download PDFInfo
- Publication number
- CA2920505C CA2920505C CA2920505A CA2920505A CA2920505C CA 2920505 C CA2920505 C CA 2920505C CA 2920505 A CA2920505 A CA 2920505A CA 2920505 A CA2920505 A CA 2920505A CA 2920505 C CA2920505 C CA 2920505C
- Authority
- CA
- Canada
- Prior art keywords
- methylene blue
- stabilised
- complex
- protonated
- blue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
- C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
- C07D279/18—[b, e]-condensed with two six-membered rings
- C07D279/20—[b, e]-condensed with two six-membered rings with hydrogen atoms directly attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Oncology (AREA)
- Toxicology (AREA)
- Hospice & Palliative Care (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Epidemiology (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Physics & Mathematics (AREA)
- Biodiversity & Conservation Biology (AREA)
- Optics & Photonics (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2013903099A AU2013903099A0 (en) | 2013-08-15 | Purification method and compounds | |
| AU2013903099 | 2013-08-15 | ||
| PCT/AU2014/000807 WO2015021500A1 (en) | 2013-08-15 | 2014-08-15 | Process for the purification of diaminophenothiazinium compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2920505A1 CA2920505A1 (en) | 2015-02-19 |
| CA2920505C true CA2920505C (en) | 2018-04-03 |
Family
ID=52467850
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2920505A Active CA2920505C (en) | 2013-08-15 | 2014-08-15 | Process for the purification of diaminophenothiazinium compounds |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US9701648B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3033331B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP6111381B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR101741235B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN105612148B (cg-RX-API-DMAC7.html) |
| BR (1) | BR112016002979A8 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2920505C (cg-RX-API-DMAC7.html) |
| DK (1) | DK3033331T3 (cg-RX-API-DMAC7.html) |
| IL (1) | IL243937A (cg-RX-API-DMAC7.html) |
| MX (1) | MX354492B (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ630569A (cg-RX-API-DMAC7.html) |
| SG (1) | SG11201601003PA (cg-RX-API-DMAC7.html) |
| TW (1) | TWI629267B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2015021500A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3375777A1 (en) * | 2017-03-15 | 2018-09-19 | MIKROCHEM spol. s.r.o. | Method for preparation of 3,7-bis-(dimethylamino)-phenothiazin-5-ium chloride or bromide |
| CN112358475B (zh) * | 2020-11-30 | 2022-09-06 | 西北师范大学 | 一种苯并吡喃鎓-吩噻嗪衍生物及其制备方法和应用 |
| CN116947783B (zh) * | 2022-04-19 | 2026-04-17 | 英科隆生物技术(杭州)有限公司 | 一种电子媒介体的提纯方法 |
| US20250270177A1 (en) * | 2022-04-19 | 2025-08-28 | Leadway (Hk) Limited | Purification method for electron mediator |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2909520A (en) | 1959-10-20 | Process for making acylated | ||
| DE1886C (de) | 1877-12-15 | 1877-12-15 | Basf Ag | Verfahren zur darstellung blauer farbstoffe aus dimethylanilin und anderen tertiaeren aromatischen monaminen |
| GB1293757A (en) | 1968-10-22 | 1972-10-25 | Paines & Byrne Ltd | A nerve stain composition |
| GB0327672D0 (en) * | 2003-11-28 | 2003-12-31 | Photopharmica Ltd | Developments in biologically active methylene blue derivatives (phenothiazines) |
| BRPI0416928A (pt) * | 2003-11-28 | 2007-01-16 | Photopharmica Ltd | desenvolvimento de derivados biologicamente ativos de azul de metileno |
| JP5186212B2 (ja) * | 2004-09-23 | 2013-04-17 | ウィスタ ラボラトリーズ リミテッド | メチルチオニニウム塩化物(mtc)などのジアミノフェノチアジニウム化合物を化学合成および精製する方法 |
| WO2006032879A2 (en) | 2004-09-23 | 2006-03-30 | Wista Laboratories Ltd. | Methods of chemical synthesis and purification of diaminophenothiazinium compounds including methylthioninium chloride (mtc) |
| MY162313A (en) * | 2006-07-11 | 2017-05-31 | Wista Lab Ltd | Methods of synthesis and/or purification of diaminophenothiazinium compounds |
| FR2903696B1 (fr) | 2006-07-12 | 2011-02-11 | Provence Technologies | Procede de purification de composes diaminophenothiazium |
| KR101888713B1 (ko) * | 2011-02-11 | 2018-08-14 | 위스타 레보레이토리스 리미티드 | 페노티아진 디아미늄 염 및 이의 용도 |
-
2014
- 2014-08-15 DK DK14836833.5T patent/DK3033331T3/da active
- 2014-08-15 MX MX2016002085A patent/MX354492B/es active IP Right Grant
- 2014-08-15 CN CN201480055983.7A patent/CN105612148B/zh not_active Expired - Fee Related
- 2014-08-15 EP EP14836833.5A patent/EP3033331B1/en active Active
- 2014-08-15 WO PCT/AU2014/000807 patent/WO2015021500A1/en not_active Ceased
- 2014-08-15 KR KR1020167005820A patent/KR101741235B1/ko not_active Expired - Fee Related
- 2014-08-15 SG SG11201601003PA patent/SG11201601003PA/en unknown
- 2014-08-15 NZ NZ630569A patent/NZ630569A/en not_active IP Right Cessation
- 2014-08-15 TW TW103128051A patent/TWI629267B/zh not_active IP Right Cessation
- 2014-08-15 US US14/911,813 patent/US9701648B2/en not_active Expired - Fee Related
- 2014-08-15 BR BR112016002979A patent/BR112016002979A8/pt not_active Application Discontinuation
- 2014-08-15 CA CA2920505A patent/CA2920505C/en active Active
- 2014-08-15 JP JP2016533750A patent/JP6111381B2/ja active Active
-
2016
- 2016-02-03 IL IL243937A patent/IL243937A/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| WO2015021500A1 (en) | 2015-02-19 |
| SG11201601003PA (en) | 2016-03-30 |
| TWI629267B (zh) | 2018-07-11 |
| EP3033331A4 (en) | 2017-01-18 |
| KR101741235B1 (ko) | 2017-05-29 |
| DK3033331T3 (da) | 2018-04-30 |
| CA2920505A1 (en) | 2015-02-19 |
| IL243937A0 (en) | 2016-04-21 |
| EP3033331A1 (en) | 2016-06-22 |
| EP3033331B1 (en) | 2018-02-21 |
| IL243937A (en) | 2017-01-31 |
| CN105612148A (zh) | 2016-05-25 |
| US20160200696A1 (en) | 2016-07-14 |
| MX2016002085A (es) | 2016-06-23 |
| MX354492B (es) | 2018-03-07 |
| BR112016002979A8 (pt) | 2020-02-04 |
| JP2016528237A (ja) | 2016-09-15 |
| AU2014306354A1 (en) | 2016-02-18 |
| US9701648B2 (en) | 2017-07-11 |
| KR20160042929A (ko) | 2016-04-20 |
| TW201527287A (zh) | 2015-07-16 |
| CN105612148B (zh) | 2018-09-14 |
| JP6111381B2 (ja) | 2017-04-05 |
| NZ630569A (en) | 2017-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5934404B2 (ja) | ジアミノフェノチアジニウム化合物の調製方法 | |
| EP3033331B1 (en) | Process for the purification of diaminophenothiazinium compounds | |
| RU2762826C2 (ru) | Способ получения хлорида или бромида 3,7-бис-(диметиламино)-фенотиазин-5-ия | |
| JP7746277B2 (ja) | メチレンブルーを製造するための方法 | |
| FI65254B (fi) | Foerbaettrat foerfarande foer framstaellning av 3-jod- och 3-bromrifamysin s | |
| AU2014306354B2 (en) | Process for the purification of diaminophenothiazinium compounds | |
| KR102558527B1 (ko) | 3,7-비스(디메틸아미노)페노티아진-5-일륨 요오다이드를 제조하기 위한 방법 | |
| US10160735B2 (en) | Process for the purification of diaminophenothiazinium compounds | |
| CN113874351B (zh) | 一种氟苯尼考的合成方法 | |
| HK1225026A1 (en) | Process for the purification of diaminophenothiazinium compounds | |
| CN100462357C (zh) | 8-溴-5,6-二氟-2-甲基喹啉的制备方法 | |
| CN110407702A (zh) | 一种艾曲波帕关键中间体3’-氨基-2’-羟基联苯-3-羧酸的制备方法 | |
| CN118908835A (zh) | 一种2-硝基-5-氟苯甲醚的制备方法 | |
| CN120208838A (zh) | 一种艾瑞昔布及及其中间体的制备方法 | |
| WO2025245928A1 (zh) | 一种10,11-二溴-5H-二苯并[b,f]氮杂䓬-5-甲酰氯的化学合成方法 | |
| JP3257371B2 (ja) | 5−フタルイミド−4−オキソペンテン酸またはそのピリジン塩の製造方法 | |
| KR101086177B1 (ko) | 항균제인(-)-9-플루오르-2,3-디히드로-3(에스)-메틸-10-(4-메틸-1-피페라지닐)-7-옥소-7에이치-피리도[1,2,3-데]-1,4-벤즈옥사진-6-카르복실산의 새로운 제조 방법 | |
| CN116836102A (zh) | 一种制备双氯芬酸钠氯代杂质(3-氯-n-(2,6-二氯苯基)吲哚-2-酮)的方法 | |
| JP2002179659A (ja) | カンファースルタムの製造方法 | |
| KR20040023246A (ko) | 디벤조티에핀 유도체의 정제 방법 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20171013 |
|
| MPN | Maintenance fee for patent paid |
Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 10TH ANNIV.) - STANDARD Year of fee payment: 10 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20240726 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT Effective date: 20240726 Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20240726 |
|
| MPN | Maintenance fee for patent paid |
Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 11TH ANNIV.) - STANDARD Year of fee payment: 11 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20250722 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20250722 |
|
| MPN | Maintenance fee for patent paid |
Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 12TH ANNIV.) - STANDARD Year of fee payment: 12 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20260721 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20260721 |